Deal Values in Medical Equipment Industry Decreased in 2015

Thursday 30 June 2016, Amsterdam

The key players “Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2015” report is an essential source of data and trend analysis on mergers and acquisitions (M&A) and financing in the medical equipment market. The report provides detailed information on M&As, equity/debt offerings, private equity (PE), venture financing and partnership transactions registered in the medical equipment industry in 2015. The report includes detailed comparative data on the number of deals and their value in the past four quarters, categorized into deal types, segments, and geographies. Additionally, the report provides information on the top PE, venture capital (VC), and advisory firms in the medical equipment industry.

Deal Values Of M&A’s Decreased In 2015

Mergers and acquisitions (M&As), including asset transactions, reported a decrease in the number of deals and deal values in 2015 with 530 deals worth USD86.2 billion, as compared to 596 deals worth USD233.2 billion in 2014.

Healthcare IT market continues to attract investors’ attention in 2015. The healthcare IT market topped in deal activity with 117 deals worth USD23.8 billion in 2015.

Capital Raising Through Issuance Of Equity Reported An Increase In 2015

Equity offerings, including initial public offerings (IPOs), secondary offerings and private investment in public equity (PIPE), an increase in the number of deals and deal values with 419 deals worth USD32 billion in 2015, as compared to 332 deals worth USD10.2 billion in 2014.

The medical equipment market reported 50 IPO deals worth USD5.5 billion in 2015, as compared to 52 deals worth USD4 billion in 2014. In addition, 143 secondary offerings worth USD21.5 billion were reported in 2015, as compared to 94 deals worth USD3.9 billion in 2014.

The medical equipment market recorded an increase in the number of PIPE deals and their values in 2015 with 226 deals worth USD5 billion, as compared to 186 deals worth USD2.4 billion in 2014.

Partnership Deals Increased In 2015

Partnerships recorded an increase in the number of partnership deals in 2015. The number of deals increased to 548 deals in 2015 from 520 deals in 2014. Out of 548 deals reported in 2015, 186 co-development deals, 146 co-marketing deals, 103 licensing deals, 87 other category deals, and 26 joint venture deals.

Venture Capital Investments Decreased In 2015

Venture capital (VC) market reported decrease in the number of deals and deal values in 2015. The market recorded 659 deals worth USD6.9 billion in 2015, as compared to 882 deals worth USD7.7 billion in 2014. Start-up stage financing deals constituted the largest segment in the market with 290 deals worth USD2.5 billion. Growth/expansion stage financing deals followed with 281 deals worth USD3.7 billion, 46 later stage financing deals worth USD568m and 42 seed stage financing deals worth USD76.7m.

Merck Global Health Innovation LLC topped the list of venture financing firms by participating in seven deals worth USD112.5m, in last one year.

North America Reported A Decrease In Deal Values In 2015

North America reported a decrease in the number of deals and deal values in 2015. The region recorded 1,575 deals worth USD155.6 billion in 2015, as compared to 1,869 deals worth USD241.1 billion in 2014.

Europe recorded an increase in the number of deals and a decrease in deal values in 2015. The region reported 628 deals worth USD32.6 billion in 2015, as compared to 614 deals worth USD110.5 billion in 2014.

The Asia-Pacific region recorded an increase in the number of deals and deal values in 2015. The region reported 332 deals worth USD14.1 billion in 2015, as compared to 281 deals worth USD11.3 billion in 2014.